Literature DB >> 7648278

Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.

F Checroune1, X J Yao, H G Göttlinger, D Bergeron, E A Cohen.   

Abstract

The 96-amino acid Vpr protein is the only virion-associated regulatory protein encoded by the human immunodeficiency virus type 1 (HIV-1). Vpr incorporation into the viral particle is most likely due to an interaction with a viral structural protein. Recent data have shown that DNA encoding for the p55 Gag precursor protein (Pr55gag) is the minimal viral genetic information necessary for Vpr incorporation. Other studies have suggested that the p6 portion of Pr55gag, which is unique to lentiviruses, is involved in Vpr incorporation. To investigate the mechanism of incorporation of Vpr into HIV-1 virions, COS-7 cells were cotransfected with ptrENV, an expression vector that encodes all of the HIV-1 regulatory proteins including Rev and Vpr, and different constructs of pIIIgagCAR, a rev-dependent Gag expression plasmid that encodes Pr55gag and the viral protease. Virions produced from gag constructs containing a premature p6 termination codon at positions Leu-1, Ser-17, Tyr-36, or Leu-44 lacked detectable Vpr. In contrast, gag constructs with double Pro-10-Pro-11 substitutions for Leu-10-Leu-11 or a premature termination codon at position Pro-49 of p6 were still able to incorporate Vpr, however, with lower efficiency than wild type. The mutations described in this study affected directly two short regions within the p6 domain, which are highly conserved among primate immunodeficiency viruses. Our results suggest that the conserved (P-T/S-A-P-P) and (L-X-S-L-F-G) motifs located near the N-terminus and C-terminus, respectively, of the p6 domain of Gag are critical for Vpr incorporation into HIV-1 virions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648278

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  13 in total

1.  Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells.

Authors:  Ferdinand Roesch; Léa Richard; Réjane Rua; Françoise Porrot; Nicoletta Casartelli; Olivier Schwartz
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

2.  The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells.

Authors:  Z Nie; D Bergeron; R A Subbramanian; X J Yao; F Checroune; N Rougeau; E A Cohen
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.

Authors:  S Sei; Q E Yang; D O'Neill; K Yoshimura; K Nagashima; H Mitsuya
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 4.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr.

Authors:  E Kondo; H G Göttlinger
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

6.  Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases.

Authors:  Yong Xiao; Gang Chen; Jonathan Richard; Nicole Rougeau; Hongshan Li; Nabil G Seidah; Eric A Cohen
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

7.  PTAP motif duplication in the p6 Gag protein confers a replication advantage on HIV-1 subtype C.

Authors:  Shilpee Sharma; Prabhu S Arunachalam; Malini Menon; Viswanath Ragupathy; Ravi Vijaya Satya; Joshua Jebaraj; Shambhu Ganeshappa Aralaguppe; Chaitra Rao; Sreshtha Pal; Shanmugam Saravanan; Kailapuri G Murugavel; Pachamuthu Balakrishnan; Suniti Solomon; Indira Hewlett; Udaykumar Ranga
Journal:  J Biol Chem       Date:  2018-05-17       Impact factor: 5.157

8.  HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

Authors:  Hichem Lahouassa; Marie-Lise Blondot; Lise Chauveau; Ghina Chougui; Marina Morel; Marjorie Leduc; François Guillonneau; Bertha Cecilia Ramirez; Olivier Schwartz; Florence Margottin-Goguet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

9.  Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly.

Authors:  B A Puffer; S C Watkins; R C Montelaro
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG.

Authors:  Akinyemi I Ojesina; Beth Chaplin; Jean-Louis Sankalé; Robert Murphy; Emmanuel Idigbe; Isaac Adewole; Ernest Ekong; John Idoko; Phyllis J Kanki
Journal:  AIDS Res Hum Retroviruses       Date:  2008-09       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.